| Sarah Holliday, COTA | |
|
3211 Amerson Dr, Pearland, TX 77584-9495 | |
| (713) 898-2151 | |
| Not Available |
| Full Name | Sarah Holliday |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapy Assistant |
| Location | 3211 Amerson Dr, Pearland, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285116871 | NPI | - | NPPES |
| 208566 | Other | TX | TBOT |
| 208566 | Other | TX | TX BOARD OF OCCUPATIONAL THERAPY EXAMINERS |
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Holliday, COTA 3211 Amerson Dr, Pearland, TX 77584-9495 Ph: () - | Sarah Holliday, COTA 3211 Amerson Dr, Pearland, TX 77584-9495 Ph: (713) 898-2151 |
News Archive
In the world depicted in an alcohol billboard, bikini-clad babes clutch icy bottles, frothy beer flows over frosty mugs and the slogan reads,Life is good. Ads like these may target adults, but children are getting the message too, a University of Florida and University of Minnesota study shows.
The United States Food and Drug Administration have issued a warning regarding some substances present in a brand of Ranitidine that could be carcinogenic. In their first warning issued on the 13th of this month, the FDA warns that one of the brands of Ranitidine, Zantac is said to contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA) at low levels. NDMA is a known carcinogen, the report reads based on lab data and is also found in the environment, food and water the report adds.
The use of an evidence-based sedation protocol for endoscopic procedures improves the quality of practice and reduces the incidence of sedation-related adverse events, according to an AGA Institute Review of Endoscopic Sedation published in the August issue of Gastroenterology , the official journal of the American Gastroenterological Association (AGA) Institute.
This study proposes a mathematical framework to analyze the effect of the viruses on type I interferon (IFN-I) signaling, which is part of the innate immune response. IFN-I brings about natural killer cell activation, which in turn causes the activation of macrophages.
› Verified 6 days ago